The impact of tralokinumab on quality of life and school in patients aged 12-17 with atopic dermatitis: results from the phase 3 ECZTRA 6 trial. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 18];7(2):s139. Available from: https://skin.dermsquared.com/skin/article/view/2026